Recent Advances in CAR T-Cell Therapy in Lymphoma: Insights from Experts at The John Theurer Cancer Center : Episode 3
CAR-T therapy in Second-Line Setting in LBCL
Lymphoma physicians from John Theurer Cancer Center comment on the use of CAR T-cell therapy in large B-cell lymphoma and the implications of clinical trial data in this setting.
EP: 1.Clinical Trial and Real-World Evidence Around CAR T-cell Therapy in LBCL
EP: 2.Selecting the Appropriate Patients and Monitoring Responses to CAR T-Cell Therapy in LBCL
Now Viewing
EP: 3.CAR-T therapy in Second-Line Setting in LBCL
EP: 4.Managing Toxicities Associated with CAR-T Therapy in LBCL
EP: 5.Brexucabtagene Autoleucel in Mantle Cell Lymphoma
EP: 6.CAR-T Therapies in the Follicular Lymphoma Treatment Landscape
EP: 7.Role of CAR-T Therapies in Acute Lymphoblastic Lymphoma
EP: 8.Recent Updates on CAR-T Therapies in Chronic Lymphocytic Leukemia
EP: 9.Next Generation of CAR-T Therapies in Lymphoma
EP: 10.Future Perspectives on CAR-T Therapies in Lymphoma
EP: 11.Selecting and Sequencing Therapies to Improve Outcomes in Patients With Lymphoma
Recent Videos
Related Content
Highlighting Insights From the Marginal Zone Lymphoma Workshop
Thomas Habermann, MD;Julie M. Vose, MD, MBA;James R. Cerhan, MD, PhD;Alexandar Tzankov, MD;Andrew D. Zelenetz, MD, PhD
February 17th 2025Podcast
Clinicians outline the significance of the MZL Workshop, where a gathering of international experts in the field discussed updates in the disease state.
